cancer vaccine

Advertisement

cGxPJobs Banner

BioVaxys Shows Durable Benefit in Ovarian Cancer Trial

Vancouver, British Columbia | January 20, 2026 — BioVaxys Technology Corp. reported positive Phase 1B/2 clinical results from its...

By cGxPwire Editor
January 21, 2026

Read More

Advertisement

cGxPJobs

Directory